← Back to Search

Probiotic

Healthy Women for Healthy Subjects (VSS Trial)

N/A
Waitlist Available
Led By Bobbi Langkamp-Henken, Ph.D.
Research Sponsored by Lallemand Health Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 14, day 28, day 35
Awards & highlights

VSS Trial Summary

This study is evaluating whether a probiotic supplement may help improve vaginal health.

Eligible Conditions
  • Healthy Subjects

VSS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 14, day 28, day 35
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 14, day 28, day 35 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Strains detection
Secondary outcome measures
Stool consistency
Stool frequency
Strains detection in skin swabs
+5 more

VSS Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy WomenExperimental Treatment1 Intervention
Healthy women between the ages of 18-40 years will be given a probiotic supplement to evaluate the detection and persistence of the strains in biological samples.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Probiotic
2013
Completed Phase 4
~3570

Find a Location

Who is running the clinical trial?

Lallemand Health SolutionsLead Sponsor
39 Previous Clinical Trials
3,711 Total Patients Enrolled
University of FloridaOTHER
1,340 Previous Clinical Trials
715,697 Total Patients Enrolled
Bobbi Langkamp-Henken, Ph.D.Principal InvestigatorUniversity of Florida
1 Previous Clinical Trials
29 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025